Skip to main content Skip to section navigation Skip to footer
Investor Relations
Back to BullFrogAI.com
BullFrog AI Holdings, Inc.
  • Overview
  • News & Events
    • Press Releases
    • In The News
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Back to BullFrogAI.com

Press Releases

News & Events

News & Events

  • Press Releases
  • In The News
  • IR Calendar
  • Presentations
  • Email Alerts
Feb 01, 2024 9:00 am EST

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

Jan 26, 2024 7:30 am EST

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

Jan 17, 2024 7:00 am EST

BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

Jan 16, 2024 8:00 am EST

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

Jan 11, 2024 4:05 pm EST

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

Dec 29, 2023 8:00 am EST

BullFrog AI Issues Letter to Shareholders

Dec 06, 2023 7:00 am EST

BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity

Oct 18, 2023 9:00 am EDT

BullFrog AI to Present at Benzinga All Access Event on October 20

Oct 05, 2023 8:00 am EDT

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

Sep 26, 2023 8:00 am EDT

BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Sitemap
©2025 BullFrog AI Holdings, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap